The VANGUARD® system is the first balloon with integrated distal filter designed to treat the challenges of lower limb disease.

Vanguard-device-image

VANGUARD®

Peripheral Dilation Balloon with Integrated Embolic Protection

Peripheral arterial disease (PAD) continues to be an under-treated condition with less than one-in-five patients suffering from the disease receiving a diagnosis by a physician. PAD is the leading cause of leg amputation in the U.S. and Europe. Specifically, occlusive disease of the superficial femoral artery (SFA) remains one of the biggest challenges especially among patients with complex chronic total occlusions and thrombotic SFA occlusions.

The Vanguard Peripheral Dilation Balloon with Integrated Embolic Protection (IEP) represents a significant leap forward in the treatment of peripheral vascular disease. It has been specifically designed and developed for treatment of PAD while simultaneously capturing and retrieving any embolic particles that may be dislodged. This breakthrough technology allows for treatment of PAD while simultaneously protecting the patient from potentially catastrophic embolic events, all achieved without increasing the time and complexity of the procedure.

The Vanguard system contains an angioplasty balloon and an integrated distal filter. Contego Medical’s IEP technology allows the physician, for the first time, to open the filter to the size appropriate for each patient’s individual anatomy, allowing for much improved capture efficiency of embolic particles.

CAUTION: VANGUARD is in development and not available for sale, worldwide.

Back>